Kidney Cancer Coverage From Every Angle
Advertisement
Advertisement

Jonathan E. Rosenberg, MD, on Urothelial Carcinoma: Results From the CheckMate 032 Trial

Posted: Monday, February 12, 2018

Jonathan E. Rosenberg, MD, of Memorial Sloan Kettering Cancer Center, discusses longer-term efficacy and safety findings on nivolumab monotherapy in metastatic urothelial carcinoma, in light of the NCCN Guidelines.